[ Price : $8.95]
FDA clears a Welldoc 510(k) to add a new feature to its digital health product BlueStar Rx which supports individuals using long-a...[ Price : $8.95]
The Motley Fool says FDAs drug competition initiative to promote generic drugs is good for consumers but can hurt some investors.[ Price : $8.95]
FDA grants Noctrix Health a Breakthrough DevicR-CASEe Designation for its wearable NTX100 neuromodulation therapy designed for tre...[ Price : $8.95]
Two stakeholders comment on an FDA draft guidance on evaluating the safety of new drugs for improving glycemic control.[ Price : $8.95]
The Association of American Physicians and Surgeons files suit against FDA in western Michigan federal court to force the agency t...[ Price : $8.95]
An FDA Regulatory Science Impact Story article touts the use of quantitative methods and modeling to modernize generic drug develo...[ Price : $8.95]
CytoDyn files a BLA for Pro 140 (leronlimab (PRO 140) for use in combination therapy for treating HIV infection.[ Price : $8.95]
A CDER online post stresses the need for accurate in vitro to in vivo translation of data as part of new drug development to treat...